TNYA PEER ANALYSIS

Tenaya Therapeutics Inc — metric-by-metric comparison with peers and the industry median

TNYATenaya Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

TNYAIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	TNYA	RTALB	MSB	TLX	Ind. Median
P/E	—	4.78	—	—	18.06
P/B	1.33	0.59●	—	6.38	3.62
EV/EBITDA	—	72.98●	—	120.20	15.13
P/S	625.48	6.52	31.30	3.24●	10.65

Financial Health
Metric	TNYA	RTALB	MSB	TLX	Ind. Median
Current Ratio	5.75●	1.21	—	1.43	5.90
Debt/Equity	9.5%	1.2%●	—	112.3%	10.9%
NetDebt/EBITDA	0.94	0.90●	—	13.13	1.15

Profitability
Metric	TNYA	RTALB	MSB	TLX	Ind. Median
Net Margin	-36,891.1%	136.3%●	-115.3%	-0.9%	-125.7%
ROE	-73.6%	15.1%●	-11.3%	-1.8%	-47.5%
ROA	-59.5%	13.1%●	-8.6%	-0.7%	-35.8%
EBITDA Margin	-33,540.9%	9.0%●	-76.6%	3.0%	-105.8%

Growth + Dividend
Metric	TNYA	RTALB	MSB	TLX	Ind. Median
Rev. Growth	—	24.0%	410.4%●	56.3%	5.1%
NI Growth	—	134.0%	—	—	12.1%
Div. Yield	—	0.0%●	0.0%●	—	0.2%
Payout	—	0.0%	0.0%	—	0.0%

Valuation
Metric	TNYA	ALXO	AGEN	CUE	ALDX	HUMA	Ind. Median
P/E	—	—	2.07	—	—	—	18.06
P/B	1.33	0.85	-0.61●	7.43	3.19	13.12	3.62
EV/EBITDA	—	—	3.18	—	—	—	15.13
P/S	625.48	—	1.08●	4.90	—	75.65	10.65

Financial Health
Metric	TNYA	ALXO	AGEN	CUE	ALDX	HUMA	Ind. Median
Current Ratio	5.75	7.21●	0.38	3.57	2.72	3.93	5.90
Debt/Equity	9.5%	3.4%	-137.6%●	15.9%	36.8%	566.9%	10.9%
NetDebt/EBITDA	0.94	1.56	2.12	0.82	1.96	-0.22●	1.15

Profitability
Metric	TNYA	ALXO	AGEN	CUE	ALDX	HUMA	Ind. Median
Net Margin	-36,891.1%	—	52.2%●	-59.6%	—	-4,840.8%	-125.7%
ROE	-73.6%	-74.2%	—	-138.5%	-51.8%●	-409.5%	-47.5%
ROA	-59.5%	-59.4%	33.4%●	-73.5%	-34.3%	-71.5%	-35.8%
EBITDA Margin	-33,540.9%	—	102.6%●	-48.4%	—	-3,956.7%	-105.8%

Growth + Dividend
Metric	TNYA	ALXO	AGEN	CUE	ALDX	HUMA	Ind. Median
Rev. Growth	—	-100.0%	24.5%	309.6%●	-100.0%	-74.0%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	0.0%	0.2%
Payout	—	—	—	—	—	0.0%	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on TNYA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.